Finding an effective supplement that aligns with your fitness goals can be daunting in the world of health and wellness.

GLP-1 drugs are driving down grocery spending, according to a new study from Cornell’s SC Johnson College of Business and ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 489.81% and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

An expert panel consisting of dietitians, doctors, nutritional epidemiologists, chefs, and weight loss researchers examined ...

Melissa Floro, 38, opened up to PEOPLE about how much her life has changed since turning to Ozempic for weight loss and ...

Structure Therapeutics has a strong cash position with a runway of 18-20 quarters, but the drug's potential is not fully ...

New insights explain why the Mediterranean diet is the healthiest way to eat even as popular medications like Ozempic shake ...

Building on the success of the anti-Myostatin program, iBio Launches New Program Featuring Myostatin + Activin A Bispecific ...

On any given day, millions of people in the U.S. are trying to lose weight. Recent data from the Centers for Disease Control and Prevention reports that a little over 40% of adults in the U.S.

In a world grappling with obesity and chronic disease, GLP-1 drugs like Ozempic are emerging as transformative game-changers.

In 2024, the state experienced developments in healthcare that will play out in 2025. Ten of them should be on your radar.